Effect of dapagliflozin according to baseline systolic blood pressure ...

Dapagliflozin had a small effect on SBP in patients with HFrEF and was superior to placebo in improving outcomes, and well tolerated, across the range of SBP ...

The figure shows effect of dapagliflozin on SBP during the first 8 months of treatment for the overall population and for each baseline SBP groups.

Effect of dapagliflozin according to baseline systolic blood pressure ...

We evaluated the efficacy and safety of dapagliflozin, which lowers systolic blood pressure (SBP),according to baseline SBP in Dapagliflozin and ...

EFFECT OF TREATMENT WITH DAPAGLIFLOZIN ACCORDING TO ...

In DAPA-HF, dapagliflozin (10mg qd), vs. placebo, reduced the risk of worsening HF and CV death. Because low systolic BP is common in HFrEF, ...

Effect of dapagliflozin according to baseline systolic blood pressure ...

Dapagliflozin had a small effect on SBP in patients with HFrEF and was superior to placebo in improving outcomes, and well tolerated, across the range of ...

Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to ...

Overall, dapagliflozin reduced SBP by 2.4 mm Hg (95% CI, 1.9-2.9; P<0.0001) compared with placebo at 48 months. The beneficial effects of ...

Blood Pressure and Dapagliflozin in Heart Failure With Mildly ...

The treatment effect of dapagliflozin on the primary outcome and Kansas City Cardiomyopathy Questionnaire total symptom score was consistent across SBP ( ...

Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to ...

Among patients with T2DM, clinical efficacy of dapagliflozin for reducing the risk of HF and renal outcomes was not affected by baseline SBP.

POS-255 EFFECT OF DAPAGLIFLOZIN ON BLOOD PRESSURE IN ...

In participants with CKD, dapagliflozin lowered systolic blood pressure with a consistent effect in participants with and without type 2 diabetes.

Effect of Dapagliflozin, Compared With Placebo, According to ...

In the DAPA-HF (Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure) trial, the sodium-glucose cotransporter 2 inhibitor ...

Dapagliflozin and Apparent Treatment-Resistant Hypertension in ...

Dapagliflozin modestly reduced systolic BP (by ≈1 to 3 mm Hg) without increasing risk of hypotension, hypovolemia, or other serious adverse events.

Blood Pressure and Dapagliflozin in Heart

BACKGROUND Optimizing systolic blood pressure (SBP) in heart failure (HF) with preserved ejection fraction carries a. Class I recommendation but with limited ...

Renal and blood pressure effects of dapagliflozin in recently ...

In patients with recent HF hospitalization, systolic blood pressure rose at 1 month by 1.4 mmHg in the placebo group versus 0.2 mmHg in the ...

AN ANALYSIS OF THE DAPA-HF TRIAL - ResearchGate

EFFECT OF TREATMENT WITH DAPAGLIFLOZIN ACCORDING TO BASELINE SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH HFREF: AN ANALYSIS OF THE DAPA-HF TRIAL.

Effect of dapagliflozin according to baseline systolic blood pressure ...

Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).

Effect of Dapagliflozin on Cardiovascular Outcomes According to ...

Meaning In this study, the effect of dapagliflozin on the relative risk for CV events was consistent across kidney function and albuminuria ...

Effects of dapagliflozin on blood pressure in hypertensive diabetic ...

Hypertension and type 2 diabetes mellitus (T2DM) are risk factors for cardiovascular disease. Dapagliflozin improves glycemic control and systolic blood ...

Dapagliflozin in Patients with Heart Failure and Reduced Ejection ...

Patients ; Heart rate — beats/min, 71.5±11.6, 71.5±11.8 ; Systolic blood pressure — mm Hg, 122.0±16.3, 121.6±16.3 ; Left ventricular ejection fraction — %, 31.2± ...

Efficacy and Safety of Dapagliflozin According to Background Use of ...

In these analyses from the DECLARE-TIMI 58 trial, dapagliflozin reduced systolic blood pressure and slowed the decline in eGFR to a similar ...

Dapagliflozin in Patients With Heart Failure and Reduced Ejection ...

Symptomatic hypotension or systolic blood pressure <95 mm Hg; Type 1 ... Effect of Dapagliflozin, Compared With Placebo, According to Baseline ...